Myotonic Dystrophy Type

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-05-06
Clinical Trial Update: Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2 [Phase 3]
A Phase 3 clinical trial evaluating mexiletine for myotonic dystrophy type 1 and type 2 has been withdrawn.